Tesaro Inc fka TSRO

[tomsylver]

TESARO Announces Participation at Three Investor Conferences

WALTHAM, Mass., April 22, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three investor conferences during the month of May, including:

The Mizuho Securities USA Third Annual Healthcare Corporate Access Day in New York City on Tuesday, May 5, 2015;
The Citi Midwest Healthcare Access Day in Chicago on Tuesday, May 5, 2015; and
The Deutsche Bank 40th Annual Health Care Conference at the Intercontinental Hotel in Boston, May 6-7, 2015. Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, are scheduled to present an overview of TESARO's business and development programs at 2:10 PM ET on Thursday, May 6. A live webcast will be available by visiting the Investors section of the TESARO website at http://www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.
About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: For additional information, please contact:

Jennifer Davis

[e-mail]